SCHEMBL8501456

SCHEMBL8501456

COc1cc2cccc(O)c2cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
MAPT P10636 3/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
TP53 P04637 2/20 0.52
LMNA P02545 1/20 0.52
CYP3A4 P08684 1/20 0.52
ALOX15 P16050 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
TSHR P16473 1/20 0.48
PDE10A Q9Y233 3/20 0.47
POLB P06746 2/20 0.46
GAA P10253 2/20 0.46
ABL1 P00519 1/20 0.46
PKM P14618 1/20 0.46
APEX1 P27695 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9383500 0.88 ESR1 (0.46) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL8955962 0.86 KDM4E (0.56) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL24250199 0.81 ERN1 (0.54) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL29620158 0.81 ALDH1A1 (0.77) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL8206713 0.81 ALDH1A1 (0.77) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL18554006 0.81 AR (0.55) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL17137307 0.80 KDM4E (0.57) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL17136965 0.80 ALDH1A1 (0.57) KDM4EALDH1A1HPGDHSD17B10GRIN2D
SCHEMBL24488059 0.80 KDM4E (0.57) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL8956482 0.78 NQO1 (0.53) KDM4EMAPTALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5656643-A QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-08-12 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed
US-5409930-A Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
WO-1992020642-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-11-26 WO disclosed